Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Immunology Today|October 8, 2014
Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleenR B Herberman, J Hiserodt, N Vujanovic, et al.
Genes & Development|November 15, 2014
Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesisLauren R Zeitels, Asha Acharya, Guanglu Shi, et al.
Cell|May 27, 2014
An essential mesenchymal function for miR-143/145 in intestinal epithelial regenerationRaghu R Chivukula, Guanglu Shi, Asha Acharya, et al.
Journal of Surgical Oncology|June 19, 2019
Perioperative anxiety and depression in patients undergoing abdominal surgery for benign or malignant diseaseHannah Williams, Mohammad Raheel Jajja, Wendy Baer, et al.
Annals of Surgical Oncology|October 21, 2022
Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?Jessica M Keilson, Adriana C Gamboa, Michael K Turgeon, et al.
International Journal of Colorectal Disease|March 18, 2024
Prophylactic defunctioning stomas improve clinical outcomes of anastomotic leak following rectal cancer resections: An analysis of the US Rectal Cancer ConsortiumKatherine Hrebinko, Vincent P Anto, Katherine M Reitz, et al.
Surgery|September 27, 2021
What's the magic number? Impact of time to initiation of treatment for rectal cancerGretchen C Edwards, Adriana C Gamboa, Michael P Feng, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 19, 2024
Comparison of outcomes of abdominoperineal resection vs low anterior resection in very-low rectal cancerRoberta L Muldoon, Alva J Bethurum, Adriana C Gamboa, et al.
Annals of Surgical Oncology|June 15, 2020
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and ChangeE Shelley Hwang, Charles M Balch, Glen C Balch, et al.
Pageof 8